当前位置:首页 - 行情中心 - 复星医药(600196) - 财务分析 - 现金流量表

复星医药

(600196)

  

流通市值:524.11亿  总市值:660.66亿
流通股本:21.18亿   总股本:26.70亿

现金流量表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金10,133,330,424.1341,012,673,920.7530,140,941,020.1919,939,164,414.42
收到的税费返还70,159,723.75481,786,382.91396,176,187.19230,414,610.43
收到其他与经营活动有关的现金227,734,707.591,677,687,518.111,014,810,121.01575,493,793.37
经营活动现金流入的平衡项目0000
经营活动现金流入小计10,431,224,855.4743,172,147,821.7731,551,927,328.3920,745,072,818.22
购买商品、接受劳务支付的现金3,479,707,841.6615,087,001,072.3711,113,466,213.167,067,198,571.36
支付给职工以及为职工支付的现金3,136,229,307.2111,060,190,509.888,472,222,959.745,888,679,822.09
支付的各项税费603,284,720.792,606,074,067.941,845,379,714.81,344,936,192.55
支付其他与经营活动有关的现金2,156,323,107.369,941,900,909.367,134,221,085.524,537,254,334.22
经营活动现金流出的平衡项目0000
经营活动现金流出小计9,375,544,977.0238,695,166,559.5528,565,289,973.2218,838,068,920.22
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额1,055,679,878.454,476,981,262.222,986,637,355.171,907,003,898
二、投资活动产生的现金流量:
收回投资收到的现金1,070,446,951.42409,580,356.92334,148,666.439,146,222.03
取得投资收益收到的现金97,771,441.761,088,797,294.921,019,256,256.61235,720,364.91
处置固定资产、无形资产和其他长期资产收回的现金净额2,256,980.45457,808,960.28238,760,527.638,705,904.26
处置子公司及其他营业单位收到的现金净额1,000,000131,424,365.62138,522,994.25134,053,430.37
收到的其他与投资活动有关的现金103,848,787.75317,711,213.1193,073,923.2398,375,301.94
投资活动现金流入的平衡项目0000
投资活动现金流入小计1,275,324,161.382,405,322,190.851,823,762,368.12516,001,223.51
购建固定资产、无形资产和其他长期资产支付的现金1,118,595,389.464,410,191,178.593,026,949,825.292,093,357,052.05
投资支付的现金74,571,745.98846,041,301.52931,718,461.75638,038,447.7
取得子公司及其他营业单位支付的现金-215,794,112.61-41,979,707.88
支付其他与投资活动有关的现金267,248,411.34546,618,969.35304,806,549.95392,574,930.06
投资活动现金流出的平衡项目0000
投资活动现金流出小计1,460,415,546.786,018,645,562.074,263,474,836.993,165,950,137.69
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-185,091,385.4-3,613,323,371.22-2,439,712,468.87-2,649,948,914.18
三、筹资活动产生的现金流量:
吸收投资收到的现金77,763,335.05204,728,600.1168,075,471.89106,070,436.32
其中:子公司吸收少数股东投资收到的现金77,763,335.05204,728,600.1168,075,471.89106,070,436.32
取得借款收到的现金6,496,493,638.7330,931,111,057.5121,739,468,572.5915,874,396,007.46
收到其他与筹资活动有关的现金137,512,764.82,233,435,288.692,057,595,013.831,932,789,359.01
筹资活动现金流入平衡项目0000
筹资活动现金流入小计6,711,769,738.5833,369,274,946.323,965,139,058.3117,913,255,802.79
偿还债务支付的现金6,575,538,058.6230,520,787,294.3321,800,975,343.7715,728,585,194.3
分配股利、利润或偿付利息支付的现金314,313,635.862,461,097,387.212,053,832,098.21846,641,558.79
其中:子公司支付给少数股东的股利、利润12,494,331.81401,677,759.28354,336,577.14182,018,449.26
支付其他与筹资活动有关的现金455,545,332.941,389,976,602.12612,621,029.02247,464,873.84
筹资活动现金流出平衡项目0000
筹资活动现金流出小计7,345,397,027.4234,371,861,283.6624,467,428,47116,822,691,626.93
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-633,627,288.84-1,002,586,337.36-502,289,412.691,090,564,175.86
四、汇率变动对现金及现金等价物的影响8,912,313.0327,989,327.43-69,635,970.1417,131,450.21
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额245,873,517.24-110,939,118.93-25,000,496.53364,750,609.89
加:期初现金及现金等价物余额9,391,449,787.119,502,388,906.049,502,388,906.049,502,388,906.04
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额9,637,323,304.359,391,449,787.119,477,388,409.519,867,139,515.93
补充资料:
净利润-3,512,440,385-1,549,731,977.11
资产减值准备-96,569,884.79-58,211,200.4
固定资产和投资性房地产折旧-1,543,138,675.38-741,754,366.29
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-1,543,138,675.38-741,754,366.29
无形资产摊销-1,038,687,347.67-523,338,046.4
长期待摊费用摊销-169,436,132.07-79,783,373.63
处置固定资产、无形资产和其他长期资产的损失--371,013,112.68--716,943.9
固定资产报废损失-21,714,578.69-1,223,970.55
公允价值变动损失-115,939,368.11-282,397,883.66
财务费用-1,254,072,720.22-623,109,420.59
投资损失--2,104,607,405.87--1,061,766,335.39
递延所得税--360,778,770.32--82,230,621.41
其中:递延所得税资产减少--254,965,765.39--35,681,035.26
递延所得税负债增加--105,813,004.93--46,549,586.15
存货的减少-238,192,005.32--5,741,136.31
经营性应收项目的减少--397,523,060.54--269,894,611.21
经营性应付项目的增加--830,705,049.71--715,515,225.74
不涉及现金收支的投资和筹资活动金额其他项目-853,585,924.85--
现金的期末余额-9,391,449,787.11-9,867,139,515.93
减:现金的期初余额-9,502,388,906.04-9,502,388,906.04
公告日期2025-04-302025-03-262024-10-302024-08-28
审计意见(境内)标准无保留意见
TOP↑